Estramustine potentiates the effects of irradiation on the dunning (R3327) rat prostatic adenocarcinoma
- 1 February 1994
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 24 (2) , 79-83
- https://doi.org/10.1002/pros.2990240205
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Evidence for a non-estrogenic cytostatic effect of estramustine on human prostatic carcinoma cells in vivoThe Prostate, 1992
- Factors influencing outcome of definitive radiotherapy for localized carcinoma of the prostateRadiotherapy and Oncology, 1989
- Estramustine binding protein and anti-proliferative effect of estramustine in human glioma cell linesBritish Journal of Cancer, 1988
- The search for therapeutic gain in the combination of radiotherapy and chemotherapyRadiotherapy and Oncology, 1988
- Stage C adenocarcinoma of the prostate. An analysis of 551 patients treated with external beam radiationCancer, 1987
- Prognostic factors in carcinoma of the prostate— analysis of rtog study 75-06International Journal of Radiation Oncology*Biology*Physics, 1987
- Blood flow in the duning R3327H rat prostatic adenocarcinoma; effects of oestradiol and testosteroneUrological Research, 1986
- Potential for radiotherapy alone in prostatic cancerCancer, 1985
- Improved control of bulky prostate carcinoma with sequential estrogen and radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Estramustine‐induced mitotic arrest in two human prostatic carcinoma cell lines du 145 and PC‐3The Prostate, 1984